Literature DB >> 1559126

Hepoxilins sensitize blood vessels to noradrenaline--stereospecificity of action.

O Laneuville1, R Couture, C R Pace-Asciak.   

Abstract

1. The vascular activity of two stereoisomers of hepoxilin A3 (HxA3) (8R and 8S) and of its glutathione conjugate, hepoxilin A3-C (HxA3-C) (8R and 8S), was investigated on rat helicoidal strips of thoracic aorta and longitudinal strips of portal vein. 2. Neither of the hepoxilins tested had a direct effect on the tone of the aortic strip or on the spontaneous contractions of the portal vein. However, the noradrenaline (NA)-induced response of these vessels, as expressed by the dose required for half maximal contraction, (EC50) was greater in HxA3 (8S)- and HxA3-C (8R)-treated aorta. Increased frequency and strength of spontaneous contractions of the portal vein were detected at lower concentrations of NA in the presence of hepoxilins. 3. The threshold dose for both hepoxilins was 10(-8) M and their effect was not dose-related beyond 10(-8) M. The effect of hepoxilin appeared after a 45 min incubation period and could be observed even if the compounds were washed out after 15 min. 4. Stereochemical specificity was observed. The 8S isomer of HxA3 was active in potentiating the NA-induced contraction of these vessels while the 8R isomer was inactive. In contrast, the 8R isomer of HxA3-C was active while the 8S isomer was inactive. In both tissues, HxA3 (8S) was more potent than its glutathione conjugate, HxA3-C (8R). 5. In calcium-free buffer or in the presence of a calcium channel blocker (nifedipine 1 microM), no potentiation of NA-induced contraction by hepoxilins could be observed, suggesting the involvement of extracellular calcium in the actions of hepoxilins.6. These experiments suggest that hepoxilins may be involved in the modulation of vascular tone and contractility.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1559126      PMCID: PMC1908669          DOI: 10.1111/j.1476-5381.1992.tb14249.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Hepoxilin A3 induces changes in cytosolic calcium, intracellular pH and membrane potential in human neutrophils.

Authors:  S Dho; S Grinstein; E J Corey; W G Su; C R Pace-Asciak
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

Review 2.  Receptors and phosphoinositide-generated second messengers.

Authors:  L E Hokin
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

3.  Hepoxilin A3 (HxA3) is formed by the rat aorta and is metabolized into HxA3-C, a glutathione conjugate.

Authors:  O Laneuville; E J Corey; R Couture; C R Pace-Asciak
Journal:  Biochim Biophys Acta       Date:  1991-06-19

4.  TPA-induced contraction of isolated rabbit vascular smooth muscle.

Authors:  H Rasmussen; J Forder; I Kojima; A Scriabine
Journal:  Biochem Biophys Res Commun       Date:  1984-07-31       Impact factor: 3.575

5.  Receptor-mediated action of hepoxilin A3 releases diacylglycerol and arachidonic acid from human neutrophils.

Authors:  S Nigam; S Nodes; G Cichon; E J Corey; C R Pace-Asciak
Journal:  Biochem Biophys Res Commun       Date:  1990-09-28       Impact factor: 3.575

6.  Aryl 4-monooxygenase and cytochrome P-450 in the aorta: possible role in atherosclerosis.

Authors:  M R Juchau; J A Bond; E P Benditt
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

7.  Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium.

Authors:  S Moncada; A G Herman; E A Higgs; J R Vane
Journal:  Thromb Res       Date:  1977-09       Impact factor: 3.944

8.  Modulation of vascular tone by 12(R)-, but not 12(S)-, hydroxyeicosatetraenoic acid.

Authors:  J Masferrer; K M Mullane
Journal:  Eur J Pharmacol       Date:  1988-07-14       Impact factor: 4.432

9.  Arachidonic acid epoxides. Isolation and structure of two hydroxy epoxide intermediates in the formation of 8,11,12- and 10,11,12-trihydroxyeicosatrienoic acids.

Authors:  C R Pace-Asciak; E Granström; B Samuelsson
Journal:  J Biol Chem       Date:  1983-06-10       Impact factor: 5.157

10.  Hepoxilin, a new family of insulin secretagogues formed by intact rat pancreatic islets.

Authors:  C R Pace-Asciak; J M Martin
Journal:  Prostaglandins Leukot Med       Date:  1984-11
View more
  7 in total

Review 1.  The hepoxilins and some analogues: a review of their biology.

Authors:  Cecil R Pace-Asciak
Journal:  Br J Pharmacol       Date:  2009-04-30       Impact factor: 8.739

2.  Biosynthesis of 14,15-hepoxilins in human l1236 Hodgkin lymphoma cells and eosinophils.

Authors:  Asa Brunnström; Mats Hamberg; William J Griffiths; Bengt Mannervik; Hans-Erik Claesson
Journal:  Lipids       Date:  2010-10-29       Impact factor: 1.880

Review 3.  Hepoxilins: a review on their enzymatic formation, metabolism and chemical synthesis.

Authors:  C R Pace-Asciak; D Reynaud; P M Demin
Journal:  Lipids       Date:  1995-02       Impact factor: 1.880

4.  Neurokinin A-induced contraction of guinea-pig isolated trachea: potentiation by hepoxilins.

Authors:  O Laneuville; R Couture; C R Pace-Asciak
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

5.  Hepoxilin A3 is the endogenous lipid mediator opposing hypotonic swelling of intact human platelets.

Authors:  A Margalit; Y Sofer; S Grossman; D Reynaud; C R Pace-Asciak; A A Livne
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

6.  Hepoxilin A3-specific binding in human neutrophils.

Authors:  D Reynaud; P Demin; C R Pace-Asciak
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

Review 7.  Role of arachidonic acid lipoxygenase metabolites in the regulation of vascular tone.

Authors:  Yuttana Chawengsub; Kathryn M Gauthier; William B Campbell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-12       Impact factor: 4.733

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.